Mitsubishi Tanabe Pharma Corp – Strategy, SWOT and Corporate Finance Report
- Pages: 55
- Published: July 2019
- Report Code: MLPH31436FSA
Mitsubishi Tanabe Pharma Corp – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company
Key Highlights
Mitsubishi Tanabe Pharma Corp (Mitsubishi Tanabe), a subsidiary of Mitsubishi Chemical Holdings Corp, identifies, develops, manufactures, procures and commercializes ethical drugs and over-the-counter (OTC) pharmaceutical products. The company develops ethical drugs for autoimmune disease, diabetes, kidney diseases, central nervous system (CNS) disorders and others. It also develops vaccines for preventing various infectious diseases. The company markets its products to wholesalers, hospitals, clinics, and drugstores. It has subsidiaries in Asia, Europe and North America. Mitsubishi Tanabe is headquartered in Chuo-ku, Osaka, Japan.
Scope
Detailed information on Mitsubishi Tanabe Pharma Corp required for business and competitor intelligence needs
A study of the major internal and external factors affecting Mitsubishi Tanabe Pharma Corp in the form of a SWOT analysis
An in-depth view of the business model of Mitsubishi Tanabe Pharma Corp including a breakdown and examination of key business segments
News about Mitsubishi Tanabe Pharma Corp, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Mitsubishi Tanabe Pharma Corp and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.
Assess Mitsubishi Tanabe Pharma Corp as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Mitsubishi Tanabe Pharma Corps business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Kissei Pharmaceutical Co Ltd
Astellas Pharma Inc
Tsumura & co
Taisho Pharmaceutical Holdings Co Ltd
Chugai Pharmaceutical Co Ltd
Daiichi Sankyo Co Ltd
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple report purchases.